Cognitive tests for early brain changes in liver cirrhosis
Part of Brain & nervous system, Digestive system clinical trials.
This study uses a set of paper-and-pencil thinking tests (called PHES) to detect a mild form of brain fog that can occur with cirrhosis, known as minimal hepatic encephalopathy. The goal is to help doctors identify this early so it can be managed before it becomes more serious.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with compensated cirrhosis (liver scarring that is stable and without recent major complications).
- You can read and write.
- You have adequate vision, hearing, and physical ability to complete paper-and-pencil cognitive tests.
- You do not have a chronic medical illness affecting your brain or other major organs (for healthy controls).
- You are not currently taking medications that affect mood or thinking (psychoactive drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares using an electronic version of a short thinking test with a traditional paper test to diagnose hepatic encephalopathy, a brain condition caused by liver disease. It aims to make diagnosis easier and more accurate for patients with cirrhosis.
This study compares two ways of testing thinking and memory in people with liver cirrhosis. It aims to see if a tablet-based test is as good as the standard paper version for detecting early signs of confusion (hepatic encephalopathy).
This study looks at people with liver cirrhosis to learn more about a condition called hepatic encephalopathy, which can cause confusion and memory problems. It aims to improve how doctors find and treat this condition.
This study is creating a new test to measure thinking and memory problems in people with liver cirrhosis. It may help doctors find these problems earlier.
This study tests a new cognitive tool to quickly and reliably detect minimal hepatic encephalopathy, a subtle brain change that can occur in people with liver disease. If you have a liver condition like fibrosis or cirrhosis and are already scheduled for a full evaluation (neuropsychological tests, MRI, EEG, and blood ammonia), this tool could help simplify future screening.
This study looks at how well simple brain tests can detect early (minimal) thinking changes related to liver cirrhosis. It may help doctors spot these changes sooner and diagnose the condition more accurately.
Hear when a new Minimal Hepatic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.